InChI=1S/C25H18N4O3/c30-22-14-7-1-4-10-17(14)26-21-20-13-25(32)16-9-3-5-11-18(16)27-24(25)29(20)23(31)15-8-2-6-12-19(15)28(21)22/h1-12,20,24,27,32H,13H2/t20-,24+,25-/m0/s1 |
HYHLSEUXMRFVND-AMDXRBSFSA-N |
C12=C(C(N3[C@H](C=4N1C(C5=C(N4)C=CC=C5)=O)C[C@]6([C@@]3(NC=7C=CC=CC67)[H])O)=O)C=CC=C2 |
|
Aspergillus alliaceus
(NCBI:txid209559)
|
of strain
ATCC20655 and 20656
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
cholecystokinin antagonist
A hormone antagonist that inhibits the action of the peptide hormone cholecystokinin.
Aspergillus metabolite
Any fungal metabolite produced during a metabolic reaction in the mould, Aspergillus .
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
|
|
cholecystokinin antagonist
A hormone antagonist that inhibits the action of the peptide hormone cholecystokinin.
|
|
View more via ChEBI Ontology
(12aR,17bS,18aS)-17b-hydroxy-13,17b,18,18a-tetrahydro-11H-indolo[3',2':4,5]pyrrolo[2,1-c]quinazolino[3,2-a][1,4]benzodiazepine-5,11(12aH)-dione
|
(+)-asperlicin E
|
ChEBI
|
asperlicin E
|
UniProt
|
23125539
|
Reaxys Registry Number
|
Reaxys
|
93413-05-9
|
CAS Registry Number
|
ChemIDplus
|
16323862
|
PubMed citation
|
Europe PMC
|
23030663
|
PubMed citation
|
SUBMITTER
|
25180619
|
PubMed citation
|
Europe PMC
|
3417561
|
PubMed citation
|
Europe PMC
|
3417562
|
PubMed citation
|
Europe PMC
|
|